Change font size here: A A A

Rosacea Specific Reference List

All decision aids are based on best available clinical evidence. Below is a condensed reference list relevant to rosacea and its treatments. More extensive details including treatment cost, side effects, etc. were obtained from resources such as UpToDate,, product monographs and more. For a more extensive list including those references, please contact us.

Arman, A., Demirseren, D. D., & Takmaz, T. (2015). Treatment of ocular rosacea: Comparative study of topical cyclosporine and oral doxycycline. International Journal of Ophthalmology, 8(3), 544–549.

Asai, Y., Tan, J., Baibergenova, A., Barankin, B., Cochrane, C. L., Humphrey, S., Lynde, C. W., Marcoux, D., Poulin, Y., Rivers, J. K., Sapijaszko, M., Sibbald, R. G., Toole, J., Ulmer, M., & Zip, C. (2016). Canadian Clinical Practice Guidelines for Rosacea. Journal of Cutaneous Medicine and Surgery, 20(5), 432–445.

Barnhorst, D. A., Foster, J. A., Chern, K. C., & Meisler, D. M. (1996). The efficacy of topical metronidazole in the treatment of ocular rosacea. Ophthalmology, 103(11), 1880–1883.

Gether, L., Overgaard, L. k., Egeberg, A., & Thyssen, J. p. (2018). Incidence and prevalence of rosacea: A systematic review and meta-analysis. British Journal of Dermatology, 179(2), 282–289.

Laser and light therapy for cutaneous vascular lesions—UpToDate . (n.d.). Retrieved March 27, 2022, from

Management of rosacea—UpToDate . (n.d.). Retrieved March 27, 2022, from

Perry, H. D., Solomon, R., Donnenfeld, E. D., Perry, A. R., Wittpenn, J. R., Greenman, H. E., & Savage, H. E. (2008). Evaluation of Topical Cyclosporine for the Treatment of Dry Eye Disease. Archives of Ophthalmology, 126(8), 1046–1050.

Rosacea: Pathogenesis, clinical features, and diagnosis—UpToDate . (n.d.). Retrieved March 27, 2022, from

Rosacea: Who gets and causes . (n.d.). Retrieved March 27, 2022, from

Schmadel, L. K., & McEvoy, G. K. (1990). Topical metronidazole: A new therapy for rosacea. Clinical Pharmacy, 9(2), 94–101.

Sobolewska, B., Doycheva, D., Deuter, C. M., Schaller, M., & Zierhut, M. (2021). Efficacy of Topical Ivermectin for the Treatment of Cutaneous and Ocular Rosacea. Ocular Immunology and Inflammation, 29(6), 1137–1141.

Tan, J., Singh, B., Song, Y., Zaher, O., Arents, B. W. M., Schaller, M., & van Zuuren, E. J. (2021). Rosacea treatments: Current standards and additional options. Dermatological Reviews, 2(6), 357–378.

Telangiectasia: Causes, Diagnosis, Prevention & Treatment . (n.d.). Hospital for Special Surgery. Retrieved March 27, 2022, from

van Zuuren, E. j., Fedorowicz, Z., Tan, J., van der Linden, M. m. d., Arents, B. w. m., Carter, B., & Charland, L. (2019). Interventions for rosacea based on the phenotype approach: An updated systematic review including GRADE assessments. British Journal of Dermatology, 181(1), 65–79.

Webster, G., Draelos, Z. d., Graber, E., Lee, M. s., Dhawan, S., Salman, M., & Magrath, G. n. (2020). A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea. British Journal of Dermatology, 183(3), 471–479.

What is rosacea? (n.d.). Acne and Rosacea Society of Canada. Retrieved March 27, 2022, from